Clinical trial / 2020
Vitamin K2 supplementation for one year did not improve vascular stiffness or other vascular health measures in patients with CKD stage 3b or 4.
A parallel-group, double-blind trial randomized 159 patients with CKD stage 3b or 4 to receive 400 μg oral vitamin K2 (n=80) or matching placebo (n=79) once daily for 1 year. The study found no differences between groups in carotid-femoral pulse wave velocity at 12 months, augmentation index at 12 months, blood pressure, B-type natriuretic peptide, or physical function. Furthermore, an updated meta-analysis of trials conducted by the authors showed no effect of vitamin K supplementation on vascular stiffness or vascular calcification measures.
- Study type
- Parallel-group, double-blind, randomized controlled trial
- Who was studied
- 159 participants aged 18+ with CKD stage 3b or 4 (mean age 66 years, 39% female, 55% stage 4)
- What was measured
- Adjusted between-group difference in carotid-femoral pulse wave velocity at 12 months
THE PAPER
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled Trial.
Witham MD, Lees JS, White M, Band M, Bell S, Chantler DJ, Ford I, Fulton RL, Kennedy G, Littleford RC, McCrea IV, McGlynn D, Panarelli M, Ralston MR, Rutherford E, Severn A, Thomson N, Traynor JP, Struthers AD, Wetherall K, Mark PB. J Am Soc Nephrol, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.